iOnctura will present late-breaking clinical data on roginolisib in patients [...]
MaaT Pharma has randomized the first patient in the IMMUNOLIFE [...]
iOnctura will present late-breaking clinical data on roginolisib in patients [...]
MaaT Pharma has randomized the first patient in the IMMUNOLIFE [...]